Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HCSG · against 437 other Healthcare companies of similar size
Ranked #188 of 438 · scores higher than 57% of peers · safety percentile 60
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)47 peers with a safety percentile of 50–59, including HCSG · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | HCSG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 414 reported | 0.03× | 0.23× | 79% | 33% | |
| BetaLower is better · 412 reported | 0.81 | 0.52 | 35% | 33% | |
| Current ratioHigher is better · 423 reported | 3.02× | 2.78× | 54% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 1.0B USD | 99 | 35 | |
| 184 | 8.0B CNY (≈$1.1B) | 61 | 48 | |
| 185 | 3.4B USD | 61 | 48 | |
| 186 | 1.6B USD | 61 | 48 | |
| 187 | 6.4B CNY (≈$894M) | 60 | 60 | |
| 188 | 1.8B USD | 60 | 80 | |
| 189 | 7.2B CNY (≈$1.0B) | 60 | 74 | |
| 190 | 3.2B USD | 59 | 65 | |
| 191 | 8.7B CNY (≈$1.2B) | 59 | 77 | |
| 192 | 14.0B CNY (≈$2.0B) | 59 | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score